DE60310605D1 - Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung - Google Patents

Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung

Info

Publication number: DE60310605D1
Authority: DE; Germany
Prior art keywords: particles; administration; compositions; nanote; production
Prior art date: 2002-07-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60310605T

Other languages

English (en)

Other versions

DE60310605T2 (de

Inventor

Fernandez Maria Jose Alonso

Lopez Carmen Remunan

Vilan Margarita Maria Cuna

Sande Maria Alonso

Jato Jose Luis Vila

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Advancell Advanced In Vitro Cell Technologies SA

Original Assignee

Advancell Advanced In Vitro Cell Technologies SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-19

Filing date

2003-07-16

Publication date

2007-02-01

2003-07-16 Application filed by Advancell Advanced In Vitro Cell Technologies SA filed Critical Advancell Advanced In Vitro Cell Technologies SA

2007-02-01 Publication of DE60310605D1 publication Critical patent/DE60310605D1/de

2007-09-27 Application granted granted Critical

2007-09-27 Publication of DE60310605T2 publication Critical patent/DE60310605T2/de

2023-07-17 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title abstract 2
239000002245 particle Substances 0.000 title 2
239000013543 active substance Substances 0.000 title 1
239000002105 nanoparticle Substances 0.000 abstract 4
239000004480 active ingredient Substances 0.000 abstract 3
LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 abstract 1
229920001661 Chitosan Polymers 0.000 abstract 1
229920002581 Glucomannan Polymers 0.000 abstract 1
125000000129 anionic group Chemical group 0.000 abstract 1
229940046240 glucomannan Drugs 0.000 abstract 1
235000019832 sodium triphosphate Nutrition 0.000 abstract 1
UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical group [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Physics & Mathematics (AREA)
Biomedical Technology (AREA)
Nanotechnology (AREA)
Optics & Photonics (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DE60310605T 2002-07-19 2003-07-16 Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung Expired - Fee Related DE60310605T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ES200201694A ES2221530B1 (es)	2002-07-19	2002-07-19	Nanoparticulas para la administracion de ingredientes activos,procedimiento para la elaboracion de dichas particulas y composicion que las contienen.
ES200201694		2002-07-19
PCT/ES2003/000372 WO2004009060A1 (es)	2002-07-19	2003-07-16	Nanopartículas para la administración de ingredientes activos, procedimiento para la elaboración de dichas partículas y composición que las contienen.

Publications (2)

Publication Number	Publication Date
DE60310605D1 true DE60310605D1 (de)	2007-02-01
DE60310605T2 DE60310605T2 (de)	2007-09-27

Family

ID=30470576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60310605T Expired - Fee Related DE60310605T2 (de)	2002-07-19	2003-07-16	Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung

Country Status (11)

Country	Link
US (1)	US20060134785A1 (de)
EP (1)	EP1561460B1 (de)
AT (1)	ATE348602T1 (de)
CA (1)	CA2492995A1 (de)
CY (1)	CY1106361T1 (de)
DE (1)	DE60310605T2 (de)
DK (1)	DK1561460T3 (de)
ES (2)	ES2221530B1 (de)
PT (1)	PT1561460E (de)
SI (1)	SI1561460T1 (de)
WO (1)	WO2004009060A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2226567B1 (es) *	2003-06-20	2006-07-01	Universidad De Santiago De Compostela	Nanoparticulas de acido hialuronico.
ES2246694B1 (es)	2004-04-29	2007-05-01	Instituto Cientifico Y Tecnologico De Navarra, S.A.	Nanoparticulas pegiladas.
ES2246695B1 (es) *	2004-04-29	2007-05-01	Instituto Cientifico Y Tecnologico De Navarra, S.A.	Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
US20080241260A1 (en) *	2005-09-28	2008-10-02	Padma Venkitachalam Devarajan	Compositions for Enhanced Absorption of Biologically Active Agents
EP1774971A1 (de) *	2005-10-14	2007-04-18	Advanced in Vitro Cell Technologies, S.L.	Nanopartikel enthaltend Chitosan und Heparin
WO2007149868A2 (en) *	2006-06-20	2007-12-27	The Regents Of The University Of California	Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
US9173852B2 (en) *	2008-04-08	2015-11-03	Tian Si Polymer Materials Technology Development Co.	Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof
JP5804453B2 (ja) *	2009-05-14	2015-11-04	国立大学法人東京大学	結晶性ポリオール微粒子及びその調製方法
EP2451484A4 (de) *	2009-07-09	2014-05-07	Polymers Crc Ltd	Biopolymer-hybrid-geldepot-ablagerungssystem
DE102009048553A1 (de)	2009-09-29	2011-03-31	Carl Zeiss Smt Gmbh	Katadioptrisches Projektionsobjektiv mit Umlenkspiegeln und Projektionsbelichtungsverfahren
US8802076B2 (en) *	2010-10-04	2014-08-12	Duke University	Compositions and methods for modulating an immune response
JP5903250B2 (ja) *	2011-11-16	2016-04-13	清水化学株式会社	徐放性組成物
KR101372834B1 (ko) *	2011-12-12	2014-03-14	전북대학교산학협력단	하이드로겔 버블 및 이의 제조방법
US9114091B2 (en) *	2013-07-05	2015-08-25	Shimizu Chemical Corporation	Sustained release solid dosage preparations
CN107970228A (zh) *	2017-11-02	2018-05-01	天津大学	一种以壳聚糖-tpp-kgm为复合壁材的纳米微囊的制备方法
CN111420067B (zh) *	2020-03-09	2021-08-27	西南交通大学	一种复合微球纳米载体及其制备方法和应用
WO2021209493A2 (en) *	2020-04-15	2021-10-21	Solyplus Gmbh	Means and methods of preventing and treating infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2688422A1 (fr) *	1992-03-11	1993-09-17	Coletica	Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant.
ES2114502B1 (es) *	1996-07-29	1999-07-01	Univ Santiago Compostela	Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.

2002
- 2002-07-19 ES ES200201694A patent/ES2221530B1/es not_active Expired - Fee Related
2003
- 2003-07-16 ES ES03765124T patent/ES2279172T3/es not_active Expired - Lifetime
- 2003-07-16 US US10/521,382 patent/US20060134785A1/en not_active Abandoned
- 2003-07-16 DK DK03765124T patent/DK1561460T3/da active
- 2003-07-16 SI SI200330701T patent/SI1561460T1/sl unknown
- 2003-07-16 CA CA002492995A patent/CA2492995A1/en not_active Abandoned
- 2003-07-16 AT AT03765124T patent/ATE348602T1/de not_active IP Right Cessation
- 2003-07-16 DE DE60310605T patent/DE60310605T2/de not_active Expired - Fee Related
- 2003-07-16 WO PCT/ES2003/000372 patent/WO2004009060A1/es not_active Ceased
- 2003-07-16 EP EP03765124A patent/EP1561460B1/de not_active Expired - Lifetime
- 2003-07-16 PT PT03765124T patent/PT1561460E/pt unknown
2007
- 2007-03-08 CY CY20071100323T patent/CY1106361T1/el unknown

Also Published As

Publication number	Publication date
DE60310605T2 (de)	2007-09-27
WO2004009060A1 (es)	2004-01-29
EP1561460A1 (de)	2005-08-10
SI1561460T1 (sl)	2007-06-30
DK1561460T3 (da)	2007-04-30
CA2492995A1 (en)	2004-01-29
ATE348602T1 (de)	2007-01-15
ES2279172T3 (es)	2007-08-16
US20060134785A1 (en)	2006-06-22
PT1561460E (pt)	2007-03-30
ES2221530A1 (es)	2004-12-16
ES2221530B1 (es)	2006-02-16
EP1561460B1 (de)	2006-12-20
CY1106361T1 (el)	2011-10-12

Publication	Publication Date	Title
DE60310605D1 (de)	2007-02-01	Nanoteilchen zur verabreichung von wirkstoffen, verfahren zur herstellung dieser teilchen und diese enthaltende zusammensetzung
Husain et al.	2017	Chitosan biomaterials for current and potential dental applications
DE60217367D1 (de)	2007-02-15	Nanopartikelzusammensetzungen enthaltend insulin
ATE536855T1 (de)	2011-12-15	Gewebegerüste zusamensetzungen zur behandlung von zahnerkrankungen
ATE213164T1 (de)	2002-02-15	Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
ATE396967T1 (de)	2008-06-15	(5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
ATE399553T1 (de)	2008-07-15	Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DK1809237T3 (da)	2009-05-04	Ophthalmisk olie-i-vand emulsion med stabilt positivt zeta-potentiale
HUP0102899A2 (hu)	2002-03-28	Eljárás gyulladásgátló, különösen fertőtlenítő hatású és/vagy sebgyógyulást elősegítő szerek alsó légutakba történő beadására szolgáló készítmények előállítására
ATE544447T1 (de)	2012-02-15	Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
FI20001696A7 (fi)	2002-01-22	Biologisesti aktiivinen materiaali
ATE332138T1 (de)	2006-07-15	Flibanserin zur behandlung extrapyramidaler bewegungsstörungen
DE602004016729D1 (de)	2008-11-06	1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
MXPA04001328A (es)	2004-05-05	Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
WO2005020928A3 (en)	2005-04-21	Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
EP1393734A4 (de)	2006-04-12	Arzneimittel gegen darmerkrankungen
WO2004067027A3 (en)	2004-09-16	Osteogenic composition
CA2317465A1 (en)	1999-07-22	Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
DE60140191D1 (de)	2009-11-26	Zusammensetzungen mit matrixproteinen zur regeneration von dentin
MXPA05013270A (es)	2006-03-17	Forma de administracion transmucosal con irritacion mucosal reducida. reducida.
BR0116653A (pt)	2004-02-17	Medicamento contendo uma poliamina como substância ativa
ATE413171T1 (de)	2008-11-15	Pharmazeutische zusammensetzungen mit ascorbinsäure zur behandlung von pilz- superinfektionen und pilz-rezidiven
DE60206280D1 (de)	2006-02-02	Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
ATE548048T1 (de)	2012-03-15	Oncomodulin zur behandlung von neurologishen erkrankungen
WO2002058532A3 (en)	2002-11-21	Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof

Legal Events

Date	Code	Title	Description
2008-01-10	8364	No opposition during term of opposition
2010-05-20	8339	Ceased/non-payment of the annual fee